Advertisement Pharmaceutical Business review - Page 638 of 5272 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
May 11, 2026

BMS’ Sotyktu secures EC approval for psoriatic arthritis

Bristol Myers Squibb (BMS) has secured approval from the European Commission (EC) for Sotyktu (deucravacitinib) to treat active psoriatic arthritis (PsA).

Continue
Safety findings for Sotyktu were generally consistent with those observed in plaque psoriasis. Credit: SaiArLawKa2 / Shutterstock.com.
May 11, 2026

ACROBiosystems upgrades HEK293 licence solution for R&D compliance

The policy applies in all global markets except Greater China, enabling access to HEK293 cell line products for R&D purposes. Credit: Gorodenkoff / Shutterstock.com.
May 8, 2026

Construction begins on Novartis’ RLT centre in Texas, US

Novartis advances RLTs for multiple cancers, supported by a global network of production and supply chain capabilities. Credit: Taljat David / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn
  2. Daiichi Sankyo and Waiv partner for ADC biomarkers
  3. Halozyme and Oruka sign agreement for Hypercon technology
  4. Citius raises $36.5m for Lymphir commercialisation
  5. MSD concludes Terns acquisition to expand CML pipeline

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography